Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

676 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.
Berry-Kravis E, Horrigan JP, Tartaglia N, Hagerman R, Kolevzon A, Erickson CA, Hatti S, Snape M, Yaroshinsky A, Stoms G; FXS-001 Investigators; Glass L, Jones NE. Berry-Kravis E, et al. Among authors: glass l. Pediatr Neurol. 2020 Sep;110:30-41. doi: 10.1016/j.pediatrneurol.2020.04.019. Epub 2020 May 23. Pediatr Neurol. 2020. PMID: 32660869 Free article. Clinical Trial.
Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.
Glaze DG, Neul JL, Kaufmann WE, Berry-Kravis E, Condon S, Stoms G, Oosterholt S, Della Pasqua O, Glass L, Jones NE, Percy AK; Rett 002 Study Group. Glaze DG, et al. Among authors: glass l. Neurology. 2019 Apr 16;92(16):e1912-e1925. doi: 10.1212/WNL.0000000000007316. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918097 Free PMC article. Clinical Trial.
Population pharmacokinetics of NNZ-2566 in healthy subjects.
Oosterholt SP, Horrigan J, Jones N, Glass L, Della Pasqua O. Oosterholt SP, et al. Among authors: glass l. Eur J Pharm Sci. 2017 Nov 15;109S:S98-S107. doi: 10.1016/j.ejps.2017.05.032. Epub 2017 May 15. Eur J Pharm Sci. 2017. PMID: 28522374 Clinical Trial.
Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.
Deacon RMJ, Hurley MJ, Rebolledo CM, Snape M, Altimiras FJ, Farías L, Pino M, Biekofsky R, Glass L, Cogram P. Deacon RMJ, et al. Among authors: glass l. Genes Brain Behav. 2017 Sep;16(7):739. doi: 10.1111/gbb.12373. Epub 2017 May 12. Genes Brain Behav. 2017. PMID: 28211606 Free article. Retracted.
M. Rebolledo, M. Snape, F. J. Altimiras, L. Farias, M. Pino, R. Biekofsky, L. Glass and P. Cogram. The above article, from Genes, Brain and Behavior, published online on 12th May 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agr …
M. Rebolledo, M. Snape, F. J. Altimiras, L. Farias, M. Pino, R. Biekofsky, L. Glass and P. Cogram. The above article, f …
676 results